Vaso Corporation (VASO)

0,2522 -0,0063 (-2,44%) Alla chiusura: 03:36PM EDT

Vaso Corporation

137 Commercial Street
Unit 200
Plainview, NY 11803
United States
516 997 4600
https://vasocorporation.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 300

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Jun Ma Ph.D.	President, CEO & Director	921,61k	N/D	1963
Mr. Jonathan P. Newton	Co-CFO & Treasurer	368,78k	N/D	1961
Mr. Michael J. Beecher CPA, CPA	Co-CFO & Secretary	149,57k	N/D	1945
Mr. Peter C. Castle	Chief Operating Officer	442k	N/D	1968
Ms. Jane Moen	President of VasoHealthcare & Director	729,44k	N/D	1980
Mr. Shen Qiuming	President of Biox Instruments Co Ltd	N/D	N/D	N/D
Mr. Randy Hill	Consultant	105k	N/D	1947
Dr. Derek Enlander M.D.	Advisor	12k	N/D	1946

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Governance aziendale

L'ISS Governance QualityScore di Vaso Corporation al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.